Matthew J. D'Onofrio - Feb 8, 2023 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
President & Chief Op. Officer
Signature
/s/ Matthew J. D'Onofrio
Stock symbol
EVOK
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 03:09 PM
Previous filing
Feb 4, 2022
Next filing
Aug 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +25K $0.00 25K Feb 8, 2023 Common Stock 25K $4.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the four-year anniversary of the date of grant, subject to the reporting person's continuous service to the issuer on such vesting date.